SCHEMBL21117665

SCHEMBL21117665

CNc1cc(F)c(S(=O)(=O)N(Cc2ccc(OC)cc2OC)c2ncns2)c(F)c1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.37
SCN1A P35498 2/20 0.37
SCN5A Q14524 2/20 0.37
SCN8A Q9UQD0 2/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
ERBB2 P04626 1/20 0.31
PRKACA P17612 1/20 0.31
RPS6KB1 P23443 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19631588 0.91 SCN9A (0.37) SCN9ASCN1ASCN5ASCN8AMEN1
SCHEMBL19631626 0.90 SCN9A (0.38) SCN9ASCN1ASCN5ASCN8AMEN1
SCHEMBL22088599 0.87 SCN9A (0.41) SCN9AMEN1KMT2AKDM4ETP53
SCHEMBL16011233 0.85 SCN9A (0.41) SCN9AMEN1KMT2AKDM4ETP53
SCHEMBL19613425 0.84 SCN9A (0.39) SCN9AMEN1KMT2AKDM4ETP53
SCHEMBL19613979 0.84 SCN9A (0.41) SCN9ASCN1ASCN5ASCN8AMEN1
SCHEMBL20237892 0.83 SCN1A (0.61) SCN1ASCN5ASCN8AKDM4ETSHR
SCHEMBL29669052 0.83 SCN1A (0.61) SCN1ASCN5ASCN8AKDM4ETSHR
SCHEMBL19631846 0.82 SCN9A (0.38) SCN9ASCN1ASCN5ASCN8AMEN1
SCHEMBL19631558 0.82 SCN9A (0.38) SCN9AMEN1KMT2AKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10815229-B1 Benzenesulfonamide compounds and their use as therapeutic agents XENON PHARMACEUTICALS INC. (CA) 2020-10-27 US disclosed
US-10662184-B2 Benzenesulfonamide compounds and their use as therapeutic agents XENON PHARMACEUTICALS INC. (CA) 2020-05-26 US disclosed
US-20190194184-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10815229-B1 Benzenesulfonamide compounds and their use as therapeutic agents SCN1A, SCN1B, SCN2B SCN9A 52/4885SCN1A 1/4885SCN5A 11/4885
US-10662184-B2 Benzenesulfonamide compounds and their use as therapeutic agents SCN1A, SCN1B, SCN2B SCN9A 42/4885SCN1A 1/4885SCN5A 5/4885
US-20190194184-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS SCN1A, SCN1B, SCN2B SCN9A 42/4885SCN1A 1/4885SCN5A 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.